Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | Doxorubicin | HCID 31703 | — |
| Reactant | Sodium chloride; water | HCID 57417360 | — |
| Product | Sodium Chloride | HCID 5234 | — |
| Product | Doxorubicin | HCID 31703 | — |
Reaction Steps
When the doxorubicin peak is less than 0.1%, the reaction mixture is filtered through a coarse sintered glass funnel to remove the beads. A brine solution (at least 30% w/v) of 1.1 kg NaCl in 3.5 L water is prepared and cooled to 0° C. The filtered reaction mixture is then slowly added to the cooled brine solution with vigorous stirring over 45 minutes. The color of the solution must remain red, a blue solution indicates that the pH needs adjustment immediately to between 5.8–6.0 by adding acetic acid. The red precipitate is filtered through a medium sintered glass funnel, washed with water and dried under vacuum pressure over P2O5 to yield MeOSuc-Leu-Ala-Leu-Dox free of any residual doxorubicin.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07214663B2 |
|---|
| Source dataset | uspto-grants-2007_05 |
|---|
| ORD ID | ord-43810e51ab6145628b3b2eab9ae8e0d2 |
|---|
| Source note | uspto-grants-2007_05 |
|---|